Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3G5U

Structure of P-glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

Summary for 3G5U
Entry DOI10.2210/pdb3g5u/pdb
Related3G60 3G61
DescriptorMultidrug resistance protein 1a, MERCURY (II) ION (2 entities in total)
Functional Keywordsp-glycoprotein, multidrug resistance, pgp, cyclic peptide, membrane protein
Biological sourceMus musculus (mouse)
Total number of polymer chains2
Total formula weight286138.77
Authors
Aller, S.G.,Yu, J.,Ward, A.,Weng, Y.,Chittaboina, S.,Zhuo, R.,Harrell, P.M.,Trinh, Y.T.,Zhang, Q.,Urbatsch, I.L.,Chang, G. (deposition date: 2009-02-05, release date: 2009-03-24, Last modification date: 2024-02-21)
Primary citationAller, S.G.,Yu, J.,Ward, A.,Weng, Y.,Chittaboina, S.,Zhuo, R.,Harrell, P.M.,Trinh, Y.T.,Zhang, Q.,Urbatsch, I.L.,Chang, G.
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.
Science, 323:1718-1722, 2009
Cited by
PubMed Abstract: P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chemically unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers. Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors. The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of approximately 6000 angstroms cubed with a 30 angstrom separation of the two nucleotide-binding domains. Two additional P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and aromatic interactions. Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry. The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.
PubMed: 19325113
DOI: 10.1126/science.1168750
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.8 Å)
Structure validation

229681

数据于2025-01-08公开中

PDB statisticsPDBj update infoContact PDBjnumon